| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000028722 |
| Receipt No. | R000024706 |
| Scientific Title | The survey of Helicobacter pylori infection rate and eradication therapy effect in Japanese junior high school students |
| Date of disclosure of the study information | 2017/08/18 |
| Last modified on | 2019/08/24 (Ver. 3) |
| Basic information | ||
| Public title | The survey of Helicobacter pylori infection rate and eradication therapy effect in Japanese junior high school students | |
| Acronym | The survey of Helicobacter pylori infection rate and eradication therapy effect in Japanese junior high school students | |
| Scientific Title | The survey of Helicobacter pylori infection rate and eradication therapy effect in Japanese junior high school students | |
| Scientific Title:Acronym | The survey of Helicobacter pylori infection rate and eradication therapy effect in Japanese junior high school students | |
| Region |
|
|
| Condition | ||||
| Condition | Helicobacter pylori infection
|
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | We examine the validity of introducing H. pylori infection test (urinary anti-H. pylori antibody test) to junior high school students and devote their significance. At the same time, for persons who are H. pylori-positive and desire sterilization, we verify the effectiveness and safety of eradication treatment. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. H. pylori infection rate in Saga prefecture junior high school third graders, infection rate of each distinction
2. Success rate of eradication treatment in H. pylori eradication treatment (primary, secondary) |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Presence or absence of Helicobacter pylori infection | |
| Interventions/Control_2 | Treatment for eradication of Helicobacter pylori | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Third grade junior high school student who got consent to the examination by the principal and the guardian for H.pylori test in Saga Prefecture
|
|||
| Key exclusion criteria | 1. Person who did not obtain consent from the person himself / herself or a guardian
2. Person responsible for research, and those who judged that the attending physician has problems with participation |
|||
| Target sample size | 70000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Pediatrics | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1 Nabeshima saga-City 849-8501 Japan | ||||||
| TEL | 0952342314 | ||||||
| matsuo@cc.saga-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Clinical Research Center | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1 Nabeshima saga-City 849-8501 Japan | ||||||
| TEL | 0952342314 | ||||||
| Homepage URL | |||||||
| kenkyu-shinsei@ml.cc.saga-u.ac.jp | |||||||
| Sponsor | |
| Institute | Saga University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saga Prefecture |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Center, Saga University Hospital |
| Address | 5-1-1 Nabeshima, Saga, 849-8501 Japan |
| Tel | 0952343400 |
| kenkyu-shinsei@ml.cc.saga-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024706 |